| An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment S Drożdżal, J Rosik, K Lechowicz, F Machaj, B Szostak, J Przybyciński, ... Drug Resistance Updates 59, 100794, 2021 | 259 | 2021 |
| Betulin and its derivatives as novel compounds with different pharmacological effects S Amiri, S Dastghaib, M Ahmadi, P Mehrbod, F Khadem, H Behrouj, ... Biotechnology advances 38, 107409, 2020 | 216 | 2020 |
| COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection K Lechowicz, S Drożdżal, F Machaj, J Rosik, B Szostak, ... Journal of Clinical Medicine 9 (6), 1917, 2020 | 214 | 2020 |
| FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy S Drożdżal, J Rosik, K Lechowicz, F Machaj, K Kotfis, S Ghavami, MJ Łos Drug resistance updates 53, 100719, 2020 | 182 | 2020 |
| Pleiotropic effects of statins: A focus on cancer M Ahmadi, S Amiri, S Pecic, F Machaj, J Rosik, MJ Łos, J Alizadeh, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1866 (12), 165968, 2020 | 120 | 2020 |
| Aspirin and its pleiotropic application J Hybiak, I Broniarek, G Kiryczyński, LD Los, J Rosik, F Machaj, ... European journal of pharmacology 866, 172762, 2020 | 95 | 2020 |
| Role of PFKFB3 and PFKFB4 in Cancer: Genetic Basis, Impact on Disease Development/Progression, and Potential as Therapeutic Targets K Kotowski, J Rosik, F Machaj, S Supplitt, D Wiczew, K Jabłońska, ... Cancers 13 (4), 909, 2021 | 89 | 2021 |
| COVID-19: Pain Management in Patients with SARS-CoV-2 Infection—Molecular Mechanisms, Challenges, and Perspectives S Drożdżal, J Rosik, K Lechowicz, F Machaj, B Szostak, P Majewski, ... Brain Sciences 10 (7), 465, 2020 | 89 | 2020 |
| The role of genetics and epigenetics in the pathogenesis of gestational diabetes mellitus J Rosik, B Szostak, F Machaj, A Pawlik Annals of Human Genetics 84 (2), 114-124, 2020 | 68 | 2020 |
| Kidney damage from nonsteroidal anti‐inflammatory drugs—Myth or truth? Review of selected literature S Drożdżal, K Lechowicz, B Szostak, J Rosik, K Kotfis, ... Pharmacology Research & Perspectives 9 (4), e00817, 2021 | 58 | 2021 |
| New therapies for the treatment of heart failure: a summary of recent accomplishments F Machaj, E Dembowska, J Rosik, B Szostak, M Mazurek-Mochol, ... Therapeutics and clinical risk management, 147-155, 2019 | 52 | 2019 |
| COVID-19: The Influence of ACE Genotype and ACE-I and ARBs on the Course of SARS-CoV-2 Infection in Elderly Patients J Sieńko, M Kotowski, A Bogacz, K Lechowicz, S Drożdżal, J Rosik, ... Clinical Interventions in Aging 15, 1231, 2020 | 40 | 2020 |
| CTLA4 antagonists in phase I and phase II clinical trials, current status and future perspectives for cancer therapy B Szostak, F Machaj, J Rosik, A Pawlik Expert opinion on investigational drugs 28 (2), 149-159, 2019 | 30 | 2019 |
| The Role of the Human Microbiome in the Pathogenesis of Pain K Ustianowska, Ł Ustianowski, F Machaj, A Gorący, J Rosik, B Szostak, ... International Journal of Molecular Sciences 23 (21), 13267, 2022 | 29 | 2022 |
| Using pharmacogenetics to predict methotrexate response in rheumatoid arthritis patients B Szostak, F Machaj, J Rosik, A Pawlik Expert Opinion on Drug Metabolism & Toxicology 16 (7), 617-626, 2020 | 26 | 2020 |
| Potential targets of gene therapy in the treatment of heart failure J Rosik, B Szostak, F Machaj, A Pawlik Expert opinion on therapeutic targets 22 (9), 811-816, 2018 | 20 | 2018 |
| Reprogramming and transdifferentiation-two key processes for regenerative medicine J Hybiak, K Jankowska, F Machaj, J Rosik, I Broniarek, A Żyluk, ... European Journal of Pharmacology 882, 173202, 2020 | 13 | 2020 |
| The evolution in our understanding of the genetics of rheumatoid arthritis and the impact on novel drug discovery F Machaj, J Rosik, B Szostak, A Pawlik Expert opinion on drug discovery 15 (1), 85-99, 2020 | 12 | 2020 |
| The Role of BiP and the IRE1α–XBP1 Axis in Rhabdomyosarcoma Pathology M Aghaei, A Nasimian, M Rahmati, P Kawalec, F Machaj, J Rosik, ... Cancers 13 (19), 4927, 2021 | 11 | 2021 |
| Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies A Zarrabi, D Perrin, M Kavoosi, M Sommer, S Sezen, P Mehrbod, ... Cancers 15 (21), 5269, 2023 | 9 | 2023 |
Saeid GhavamiAssociate Professor, Department of Human Anatomy and Cell Science, University of Manitoba, Canada在 med.umanitoba.ca 的电子邮件经过验证
Saeid GhavamiAssociate Professor, Department of Human Anatomy and Cell Science, University of Manitoba, Canada在 med.umanitoba.ca 的电子邮件经过验证